BioGredient II ApS: Financial statements 2019
CVR: 37759724
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
BioGredient II ApS (CVR 37759724) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -40,000 the year before. Equity in the 2019 report amounted to DKK 0.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 0 | 0 | 0 | - |
| 2018 | - | - | -40 t. | 0 | - |
| 2017 | - | - | -10 t. | 40 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BioGredient II ApS
BioGredient II ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Nordic-Umami ApS. The management consists of Anders Hoffmann Kønigsfeldt. The company is owned by DACWR ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -14,447.